Testing effectiveness (Phase 2)Study completedNCT06670534What this trial is testingA Dose-finding Study of JMKX003142 in Treatment of Renal EdemaWho this might be right forEdema SecondaryEdema Leg Jemincare 133
Large-scale testing (Phase 3)Study completedNCT04676334What this trial is testingCATCH-R: A Rollover Study to Provide Continued Access to RucaparibWho this might be right forMetastatic Castration-Resistant Prostate CancerOvarian CancerEpithelial Ovarian Cancer+3 more pharmaand GmbH 34
Testing effectiveness (Phase 2)Ended earlyNCT01816048What this trial is testingNaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone MetastasisWho this might be right forProstatic NeoplasmsProstate Cancer University of Wisconsin, Madison 8
Large-scale testing (Phase 3)WithdrawnNCT03717038What this trial is testingSym004 Versus TAS-102 in Patients With mCRCWho this might be right forMetastatic Colorectal CancerColorectal Cancer MetastaticCarcinoma Symphogen A/S
Not applicableWithdrawnNCT02022904What this trial is testingProstate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition BiologyWho this might be right forProstate Cancer Duke University
Testing effectiveness (Phase 2)Active Not RecruitingNCT03217747What this trial is testingAvelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmCastration-Resistant Prostate CarcinomaMalignant Solid Neoplasm+7 more M.D. Anderson Cancer Center 173
Large-scale testing (Phase 3)Active Not RecruitingNCT07109414What this trial is testingTrial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)Who this might be right forPlatinum-resistant Ovarian Cancer Novita Pharmaceuticals, Inc. 380
Testing effectiveness (Phase 2)Ended earlyNCT01681433What this trial is testingOGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving AbirateroneWho this might be right forProstate CancerMetastatic Castrate-Resistant Prostate CancerPSA Costantine Albany 72
Testing effectiveness (Phase 2)Ended earlyNCT02844582What this trial is testingCabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate CancerWho this might be right forHormone-Resistant Prostate CancerStage IV Prostate Adenocarcinoma University of California, Davis 2
Not applicableStudy completedNCT07241403What this trial is testingChronic Inflammation, Plasma Proteins Signature, Survival Outcomes and Clinical Response, in Patients Receiving Bevacizumab Combined With Oxaliplatin-based Chemotherapy (Bev/OX) or Bevacizumab Combined With Irinotecan-based Chemotherapy (Bev/IRI)Who this might be right forColorectal CancerResistanceBevacizimab+1 more Second Affiliated Hospital of Nanchang University 698
Post-approval studies (Phase 4)Study completedNCT02441894What this trial is testingCombination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate CancerWho this might be right forProstate Cancer Sanofi 21
Not applicableStudy completedNCT00264082What this trial is testingAssessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone MetastasisWho this might be right forBreast Cancer University of Louisville 30
Testing effectiveness (Phase 2)Study completedNCT02711956What this trial is testingZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-Resistant Prostate Cancer Zenith Epigenetics 75
Not applicableEnded earlyNCT04370522What this trial is testingCharacterization of Innate Immune System in Patients With Luminal Advanced Breast CancerWho this might be right forMetastatic Breast Cancer Spanish Breast Cancer Research Group 32
Early research (Phase 1)Ended earlyNCT04634344What this trial is testingAssess the Safety, Tolerability, PK and Anti-tumor Efficacy of DZD2269 in Patients With MCRPCWho this might be right forMetastatic Castration Resistant Prostate Cancer Dizal Pharmaceuticals 16
Not applicableUnknownNCT05188911What this trial is testingAnalysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA TrialWho this might be right forProstate CancerCastration-resistant Prostate CancerMetastatic Disease Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT01695044What this trial is testingPSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)Who this might be right forProstate Cancer Progenics Pharmaceuticals, Inc. 119
Testing effectiveness (Phase 2)Study completedNCT02601014What this trial is testingBiomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7Who this might be right forProstate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Early research (Phase 1)Looking for participantsNCT06999187What this trial is testingDR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasWho this might be right forTriple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more Dren Bio 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT05011188What this trial is testingFOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate CancerProstate Cancer Rahul Aggarwal 44